Skip to main content
. 2016 May 8;2016(5):CD010529. doi: 10.1002/14651858.CD010529.pub2

Yim 1996.

Methods Single centre RCT of talc insufflation versus talc slurry for symptomatic MPE (Hong Kong)
Participants Inclusion: established, symptomatic MPE (all cell types); dyspnoea improved after tube thoracostomy or large volume thoracentesis
Exclusion: Karnofsky score < 30%; FEV1 < 0.5 L; trapped lung; chemotherapy or radiotherapy within six months
57 participants randomised
Interventions Talc insufflation group: all participants underwent a GA with one lung ventilation in the lateral decubitus position. 10 mm port inserted. Adehsions and loculations broken down. 5 g talc insufflated into the chest. 28 Fr tube at end of procedure, connected to suction. Drain removed when < 50 ml/24 hours drainage
Talc slurry group: chest tube. 5 g talc in 50 ml saline and 10 ml 2% lidocaine instilled through the drain. Drain clamped for two hours and participant turned Drain reconnected to suction and removed when output < 50 ml/24hours
Outcomes Radiological recurrence of effusion
Complications of the procedure
Post‐procedure chest drain duration
Length of hospital stay
Parenteral meperidine use
Notes People with trapped lung excluded from trial entry
Included in network meta‐analysis for pleurodesis efficacy and mortality
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not stated
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Unable to blind due to nature of the interventions
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Adverse event reporting and length of stay may be biased by lack of blinding. Not stated whether radiology was reported blindly
Incomplete outcome data (attrition bias) 
 All outcomes Low risk All data reported. Survial data not entirely clear
Selective reporting (reporting bias) Low risk All outcomes reported on
Other bias Low risk Unclear how many patients in the poudrage arm had a drain in situ at the time of trial entry. Pleurodesis success only defined using radiology